Valeant Pharmaceuticals International, Inc. seeks acquisitions. "Also from iNova, we got a South African business which has been growing very nicely. It is a little jewel.

It is actually one of the few places around the world where you actually get price and we are excited about that and we are looking to add to that business probably with smaller little bolt-on acquisitions," said Howard Schiller, Executive Vice President AND Chief Financial Officer, Valeant.